At the moment, it appears that the controversial Verifying Accurate Leading-edge IVCT Development (VALID) Act will have a hard time passing in Congress. The bill, which is intended to shift regulation of laboratory-developed tests (LDTs) to the federal Food and Drug Administration, fell to the wayside during year-end spending negotiations in Congress. Despite a strong […]
To access this post, you must purchase The Dark Report.